Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2013 (2013), Article ID 837906, 2 pages
http://dx.doi.org/10.1155/2013/837906
Case Report

Perioperative Management of Type 2N Von Willebrand’s Disease with Recombinant Factor VIII in a Patient Undergoing Knee-Replacement Surgery

Department of Haematology, Queen's Centre for Oncology and Haematology, Castle Hill Hospital, Castle Road, Cottingham, East Riding of Yorkshire HU16 5JQ, UK

Received 19 November 2012; Accepted 2 January 2013

Academic Editors: B. Longo-Mbenza and M. Singh

Copyright © 2013 Srivasavi Dukka and David John Allsup. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. H. B. Bolton-Maggs, D. Lillicrap, J. Goudemand, and E. Berntorp, “von Willebrand disease update: diagnostic and treatment dilemmas,” Haemophilia, vol. 14, supplement 3, pp. 56–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Sadler, U. Budde, J. C. J. Eikenboom et al., “Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor,” Journal of Thrombosis and Haemostasis, vol. 4, no. 10, pp. 2103–2114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. E. J. Favaloro, D. Lillicrap, M. A. Lazzari et al., “von Willebrand disease: laboratory aspects of diagnosis and treatment,” Haemophilia, vol. 10, supplement 4, pp. 164–168, 2004. View at Google Scholar · View at Scopus
  4. M. W. Dennis, V. Clough, and C. H. Toh, “Unexpected presentation of type 2N von Willebrand disease in pregnancy,” Haemophilia, vol. 6, no. 6, pp. 696–697, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Goudemand, I. Scharrer, E. Berntorp et al., “Pharmacokinetic studies on Wilfactin, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods,” Journal of Thrombosis and Haemostasis, vol. 3, no. 10, pp. 2219–2227, 2005. View at Publisher · View at Google Scholar · View at Scopus